FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
0:00
3:00
Listen to a soundcast of the August 31, 2021 FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
Weitere Episoden von „FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)“
Verpasse keine Episode von “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” und abonniere ihn in der kostenlosen GetPodcast App.